Benzinga | May 5, 2021 07:30AM EDT

Editas Medicine Q1 EPS $(0.86) Misses $(0.75) Estimate

Editas Medicine (NASDAQ:EDIT) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $(0.75) by 14.67 percent. This is a 24.64 percent decrease over losses of $(0.69) per share from the same period last year.